The best indicator for Pfizer (PFE)
We backtested 382 indicators across daily, weekly and hourly charts on real Pfizer (PFE) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Where Pfizer (PFE) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Fibonacci Pivots
On the weekly chart, this is the strongest risk-adjusted edge we found for Pfizer (PFE) over ~54.2 years — trailing buy-and-hold by 1.8% CAGR.
Pfizer (PFE) on the weekly chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Pfizer (PFE) — trailing buy-and-hold by 4.6% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Fibonacci Pivots ✓ | Weekly | 8.3% | 0.56 | -43.3% | 56.0% | 432 | -1.8% |
| 2 | CCI (200) ✓ | Weekly | 9.7% | 0.55 | -53.6% | 39.1% | 23 | -0.4% |
| 3 | Trend Intensity Index ✓ | Weekly | 9.2% | 0.54 | -51.2% | 62.5% | 16 | -0.9% |
| 4 | SMC: Change of Character ✓ | Weekly | 9.3% | 0.54 | -44.2% | 52.0% | 25 | -0.8% |
| 5 | Positive Volume Index ✓ | Weekly | 8.8% | 0.52 | -56.0% | 65.0% | 20 | -1.3% |
| 6 | EMA 200 Trend ✓ | Weekly | 9.2% | 0.52 | -51.7% | 42.1% | 38 | -0.9% |
| 7 | SMA 200 Trend ✓ | Weekly | 9.0% | 0.52 | -48.0% | 45.8% | 24 | -1.1% |
| 8 | T3 10/40 Cross ✓ | Weekly | 8.3% | 0.52 | -52.1% | 53.8% | 26 | -1.7% |
| 9 | Vegas Tunnel ✓ | Weekly | 8.5% | 0.51 | -46.3% | 36.4% | 33 | -1.6% |
| 10 | Pivot Points (Standard) ✓ | Weekly | 7.0% | 0.51 | -48.2% | 55.2% | 388 | -3.1% |
| 11 | SMA 20/80 Cross ✓ | Weekly | 8.5% | 0.51 | -49.3% | 57.9% | 19 | -1.6% |
| 12 | TRIMA 200 Trend ✓ | Weekly | 8.4% | 0.5 | -50.9% | 39.1% | 23 | -1.7% |
| 13 | T3 15/60 Cross ✓ | Weekly | 7.8% | 0.5 | -53.2% | 61.1% | 18 | -2.2% |
| 14 | Intraday Momentum Index ✓ | Daily | 7.9% | 0.49 | -52.5% | 69.0% | 158 | -2.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on Pfizer (PFE)
2 of 719 tested setups beat buy-and-hold on Pfizer (PFE) outright. Another 144 could get there with leverage they would survive — but 412 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| Murrey Math Lines | 1 | none needed | 3.09× |
| Trade Volume Index | 1 | none needed | 1.74× |
| Volatility Stop (ATR) | — | 1.39× | 2.69× |
| Bollinger Mean-Reversion | — | 1.65× | 3.55× |
| Fibonacci Bands | — | 1.65× | 3.55× |
| Order-Flow Reversion | — | 1.69× | 4.33× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For Pfizer (PFE), Fibonacci Pivots on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Pfizer’s signal flips
We track Pfizer daily. Its backtested best indicator, Fibonacci Pivots (Weekly), is long right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.